SCHEMBL4152816

SCHEMBL4152816

CCOS(=O)(=O)C=Cc1ccc(Br)cc1.[Li]CCCC

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 20/20 0.61
PTPN2 P17706 5/20 0.51
PTPN11 Q06124 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3782484 0.89 PTPN1 (0.71) PTPN1PTPN2PTPN11
SCHEMBL3782486 0.89 PTPN1 (0.71) PTPN1PTPN2PTPN11
SCHEMBL13012004 0.78 PTPN1 (0.73) PTPN1PTPN2PTPN11
SCHEMBL12425743 0.73 PTPN1 (0.71) PTPN1PTPN2PTPN11
SCHEMBL14244758 0.73 PTPN1 (0.71) PTPN1PTPN2PTPN11
SCHEMBL1240288 0.73 PTPN1 (0.71) PTPN1PTPN2PTPN11
SCHEMBL4975794 0.73 PTPN1 (0.70) PTPN1PTPN2PTPN11
SCHEMBL952477 0.73 PTPN1 (0.70) PTPN1PTPN2PTPN11
SCHEMBL1239683 0.72 PTPN1 (0.79) PTPN1PTPN2PTPN11
SCHEMBL12426122 0.72 PTPN1 (0.79) PTPN1PTPN2PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234993-A1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY AstraZeneca AB (SE) 2010-10-06 EP disclosed
WO-2009082347-A1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2009-07-02 WO disclosed